Stay updated with breaking news from Statistical Analysis Plan. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
In the Phase IIb NATIVE, lanifibranor met both the primary and key secondary endpoints, including NASH resolution with no worsening of fibrosis and improvement of liver fibrosis with no worsening of NASHNATIVE
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
In a pilot randomised controlled trial, Simon Gilbody and colleagues present preliminary findings from a telephone delivered intervention (behavioural activation) designed to prevent depression and loneliness among socially isolated older people with long term conditions.
Toronto, ON (PRWEB) May 25, 2021 -- Clinical development has more partnerships and collaborations than ever before with many companies acquiring assets from
Search jobs 24-May-2021 Abivax reports excellent efficacy and safety of ABX464 in phase 2b clinical trial in ulcerative colitis and plans to proceed to phase 3 DGAP-News: ABIVAX / Key word(s): Study results 24.05.2021 / 18:30 The issuer is solely responsible for the content of this announcement. Abivax reports excellent efficacy and safety of ABX464 in phase 2b clinical trial in ulcerative colitis and plans to proceed to phase 3 Primary endpoint (statistically significant reduction of Modified Mayo Score [1]) was met with once-daily ABX464 (25m...